series-c-plus
Stage
About
Ascelia Pharma AB is a biopharmaceutical company focused on developing and commercializing novel drugs for rare cancer conditions, with clinical-stage candidates Orviglance® and Oncoral.
Explore Ascelia Pharma AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.